"Andrea Dunaif, MD - PCOS Prevalence In Women With Type 2 Diabetes" - Kevin Kunzmann
The large-scale, transparent health issues of the United States are beneficial to researchers — if not just because of patient sample size opportunities. Studies and analysis presented at the 2018 American Diabetes Association 78th Scientific Sessions this week featured U.S.-based trials that sometimes included thousands of patients with diabetes being treated in real-world settings. Andrea Dunaif, MD, chief of the division of endocrinology, diabetes and bone disease for the Mount Sinai Health System, said her interests in sessions had particularly leaned towards those focused on polycystic ovary syndrome in women. Dr. Dunaif noted that much of the newest data in PCOS has brought clearer answers to its characteristics and association to conditions such as type 2 diabetes. Though more work needs to be done in clinical settings both in and outside of the United States, Dr. Dunaif found take-home messages pertaining to patient screening.
– Andrea Dunaif, MD, Chief, Division of Endocrinology, Diabetes and Bone Disease, Mount Sinai Health System